MSB 1.05% 96.0¢ mesoblast limited

Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain, page-152

  1. 30,341 Posts.
    lightbulb Created with Sketch. 1841
    The FDA doesn't understand what it's asking and keeps making changes because this is a revolution in medical practice.

    And they're either plodding bureaucrats or compromised advisors in a conflict-of-interest-riddled agency.

    I can't wait for the new FDA head to take up the appointment and start making the necessary changes.

    Even the FDA has written a report about urgently needed reforms within and plenty of expert reports have also been written showing how it's impeding approval of technological innovation with valuable unmet patient needs the result.

    https://jamanetwork.com/journals/jama/article-abstract/2758582

    https://www.mercatus.org/system/files/thierer-fda-reform-models-ep-v1_0.pdf

    There are plenty out there just google it.



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.